Ligand Pharmaceuticals



金融业
股票价格
USD
资产
USD 1.48B
现金及等价物
USD 664.52M
销售成本
USD 11.9M
流动资产
USD 753.92M
流动负债
USD 30.54M
债务
USD 5.74M
EBIT
USD 158.89M
EBITDA
USD 20.9M
员工
68
EPS每股收益
USD 3.09
股本和储备
USD 950.17M
销售毛利
USD 155.28M
债务利息支出
USD 910K
利息收入
USD 1.62M
贷款资金
USD 445.49M
市值
USD 3.3B
净收入
USD 117.27M
营业费用
USD 8.29M
营业利润
USD 158.89M
普通股股本
USD 20K
PE价格收益
USD 60.65
税前利润
USD 141.14M
销售收入
USD 115.46M
销售和管理费用
USD 28.45M
股票
USD 11.9M
贸易债权人
USD 27.76M
应收帐款人
USD 58.1M


Ebit 更改 日
Agenus USD -13.31M 19.08M 2025-03
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD -4.28M 3.58M 2025-03
Arrowhead Research USD 40.81M 17.01M 2025-12
Baxter International USD 201.2M 70.8M 2025-09
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 3.76B 1.69B 2025-09
Heron Therapeutics USD -4.46M 5.76M 2024-09
Insmed USD -261.35M 7.48M 2025-09
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
MacroGenics USD 20.16M 55.51M 2025-09
Merck USD 6.24B 1.32B 2025-12
Pacira USD 13.15M 2.92M 2025-09
Pfizer USD 4.65B 71M 2025-12
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Veracyte USD 23.11M 8.8M 2025-09


Ligand Pharmaceuticals - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.